Market Alert: GRNE Up Sharply in Early Trading Company: Green Endeavors Inc. (OTCQB: GRNE) Last Trade:

Price: 0.0003 Change (%): + 0.0001 (50.00) Volume: 1,000,000 http://0webinfo.com/ss/link.phpM15558&N1066&C8e970abf490d59bca7e65165b8238f56&L3178 ———– Recent News ———– GRNE Reports Salons Revenue of $246,167 in April 2012; Up 7.3% Over April 2011 SALT LAKE CITY, UT=E2(Marketwire -05/15/12)- Green Endeavors, Inc. (GRNE), a majority owned subsidiary of Nexia Holdings, Inc. (NXHD), announced continued revenue growth in the month of April.

Green Endeavors is reporting that the combined unaudited revenues for both Landis Lifestyle Salon locations were $246,167 for the month of April 2012; which is an increase of $16,793 or 7.3% compared to April 2011. The newer Marmalade salon reported April 2012 sales of $71,966; a $5,646 or 8.5% increase from the comparable month of 2011.

Our flagship Liberty Heights salon reported revenues in April 2012 of $174,201; an $11,417 or 6.8% increase over April 2011.

Read More =C2 http://0webinfo.com/ss/link.phpM15558&N1066&C8e970abf490d59bca7e65165b8238f56&L3223Company: Medical Marijuana Inc. (Pink Sheets: MJNA) Last Trade:

Price: 0.048 Change (%): + 0.00 (00.00) Volume: 341,003 http://0webinfo.com/ss/link.phpM15558&N1066&C8e970abf490d59bca7e65165b8238f56&L2727 ———– Recent News ———– Medical Marijuana, Inc. Submits Updated 15c2-11 Filing DENVER, May 17, 2012 /PRNewswire/ – Medical Marijuana, Inc.

(MJNA), has commenced the first step in the process for its 15c2-11 filing status with BMA Securities located in 608 Silver Spur Road, Suite 100, Rolling Hills Estates, CA 90274. The filing of a 15c2-11 is designed to allow non-reporting public company=E2s securities to be quoted on the National Association of Securities Dealers=E2 (=E2NASD=E2) Over-the-Counter Bulletin Board (=E2OTCBB=E2) by filing required disclosures. Once approved, this filing status causes another level of transparency which will be attractive to additional market makers and brokerage firms, thereby providing increased visibility to a broader set of investors.

Read More =C2 http://0webinfo.com/ss/link.phpM15558&N1066&C8e970abf490d59bca7e65165b8238f56&L3256 ——————————————— IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY ——————————————— SmallCapVoice (SCV) is an electronic publication.

Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice.

We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. opt out of our distribution list at any time by clicking on the =E2

GRNE · MJNA · NXHD · SALT

News Alert: Good Step for MJNA to Uplisting Company: Medical Marijuana Inc. (Pink Sheets: MJNA) Last Trade:

Price: 0.05 Change (%): – 0.004 (7.41) Volume: 2,165,524 http://0webinfo.com/ss/link.phpM15558&N1064&C8e970abf490d59bca7e65165b8238f56&L2727 ———– Recent News ———– Medical Marijuana, Inc. Submits Updated 15c2-11 Filing DENVER, May 17, 2012 /PRNewswire/ – Medical Marijuana, Inc.

(MJNA), has commenced the first step in the process for its 15c2-11 filing status with BMA Securities located in 608 Silver Spur Road, Suite 100, Rolling Hills Estates, CA 90274. The filing of a 15c2-11 is designed to allow non-reporting public company=E2s securities to be quoted on the National Association of Securities Dealers=E2 (“NASD”) Over-the-Counter Bulletin Board (“OTCBB”) by filing required disclosures. Once approved, this filing status causes another level of transparency which will be attractive to additional market makers and brokerage firms, thereby providing increased visibility to a broader set of investors.

“This is a significant step in the growth and development of Medical Marijuana, Inc.,” said Michael Llamas, President of Medical Marijuana, Inc. “As we continue to mature as a company, it is critical to our growth path that we can access new and additional capital markets and investors who understand the value that a company like ours can create.

This filing, and the subsequent approval will allow us to educate a much broader market about the shareholder value we are building through our comprehensive set of portfolio companies focused on this explosive growth industry.” About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

For more information, please visit the company=E2s website at:

www.MedicalMarijuanaInc.com.

Read More =C2 http://0webinfo.com/ss/link.phpM15558&N1064&C8e970abf490d59bca7e65165b8238f56&L3256 ——————————————— IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY ——————————————— SmallCapVoice (SCV) is an electronic publication.

Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice.

We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. opt out of our distribution list at any time by clicking on the =E2

MJNA

—————— Hot Stock To Watch —————— Company: Medical Marijuana, Inc. (Pink Sheets: MJNA) Last Trade:

Price: 0.0447 Change (%): + 0.0072 (19.20) Volume: 3,514,302 http://0webinfo.com/ss/link.phpM15558&N1058&C8e970abf490d59bca7e65165b8238f56&L2727 ———– Recent News ———– Medical Marijuana, Inc. Announces First Quarter 2012 Results Company Sees 400 Plus Percent Quarter-over-Quarter and an Accumulative 12,000 Plus Percent Year-over-Year Revenue Growth Fueled by Licensing Agreements and Acquisitions SAN DIEGO, May 15, 2012 /PRNewswire/ =E2 Medical Marijuana, Inc. (OTC: MJNA), one of the medical marijuana (MMJ) industry=E2s premier cannabis and hemp industry innovators, today announced its first quarter earnings. The company earned net income of approximately $1.21 million on gross revenues of $1.79 million for the quarter ended March 31, 2012. This represents a gross revenue increase of 400 plus percent quarter-over-quarter when compared to revenue of $430,000 for the quarter ended December 31, 2011 and an accumulative 12,000 plus percent increase in revenue since the same quarter last year. Operating expenses were approximately $580,000 for the quarter.

=E2The first quarter of 2012 brought into clear focus all that we have been working towards since Cannabank=E2s initial investment into Medical Marijuana, Inc. about a year ago,=E2 said Michael Llamas, President of Medical Marijuana, Inc.

=E2We have spent this last year essentially getting our house in order by clarifying the growth strategy and systematically identifying, acquiring and growing early stage companies across the spectrum of the MMJ industry from product development to retail sales. As witnessed by our strong quarter-over-quarter and year-over-year growth, there is tremendous opportunity in this industry. We have the capital and the systems in place to buy, incubate and grow the best companies across multiple categories within the industry. At the same time, there is aggressive natural attrition of other companies and whole categories as the industry right sizes itself-which creates further opportunities and differentiation for Medical Marijuana, Inc. this truly is the perfect storm for acquiring income producing businesses.

Read More =C2 http://0webinfo.com/ss/link.phpM15558&N1058&C8e970abf490d59bca7e65165b8238f56&L3237 ——————————————— IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY ——————————————— SmallCapVoice (SCV) is an electronic publication.

Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice.

We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. opt out of our distribution list at any time by clicking on the =E2

MJNA

Medical Marijuana Inc.

2665 Ariane Drive Suite 207 San Diego, CA 92117 Toll Free: 888-OTC-MJNA (888-682-6562) Fax: 888-651-0349 http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2953 ———– MARKET INFO ———– Pink Sheets: MJNA Get a detailed quote for MJNA http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2954 Shares Outstanding: 558,565,764 as of Dec 31, 0211 Float: 129,999,314 as of Dec 31, 2011 Authorized Shares: 600,000,000 as of Dec 31, 2011 Transfer Agent: First American Stock Transfer, Inc.

——————— Join Our Mailing List ——————— http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2955 —————- LATEST HEADLINES —————- Dixie Elixirs & Edibles and PhytoSPHERE Systems, Portfolio Companies of Medical Marijuana, Inc, Grow Relationship with New Licensing Agreement http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2933 Medical Marijuana, Inc.=E2s Dixie Elixir and Edibles Brand to Launch First non-THC-Based Line of Health and Wellness Products http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L3105 Medical Marijuana Inc (OTC: MJNA) Announces Its Wholly Owned Subsidiary Wellness Managed Services Signs An Additional Management Contract Increasing Annual Revenue By $1,700,000, Quarter Over Quarter Revenue Increase On Pace To Maintain 100% Compounded Quarterly http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L3105 ————– KEY EXECUTIVES ————– Michelle Sides – COO Michael Llamas – President Robert Plomgren – CFO, Secretary, Treasurer —— VIDEOS —— Medical Marijuana Stops Spread of Breast Cancer http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2956 Cannabinoid System in Neuroprotection, Raphael Mechoulam,PhD http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2957 Medical Marijuana – The Science http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2958 Anti-Tumor Properties Of Cannabinoids http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2959 Cannabis Cures Cancer http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2960 Cannabinoid Patent; Cannabis & Movement Disorders – Dr. Ramos http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2961 CNN: Cannabis may treat memory loss http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2962 ——————— Investment Highlights ——————— *Medical Marijuana Inc., has seen an explosion in revenue, up nearly 4,000% since new management. New acquisitions expected to continue this trend in revenue growth.

*Company has a portfolio of Patented and Proprietary Cannabinoid based products and delivery methods for the Pharmaceutical industry.

*Only Pharmaceutical grade organic cannabinoid production technology. Health & Wellness products to hit the US marketplace within weeks.

*Actively acquiring businesses and technology in the sector.

*Does not grow, or sell marijuana. Owns patented and proprietary methods for governments, municipalities to implement production, tracking, packaging and integration of pharmaceutical grade medical herbs.

*Secured $4,000,000 in liquidity, non recourse, non dilution development financing this year.

*Medical Marijuana, Inc. has acquired all intellectual property, research and development, formulas and recipes associated with medical cannabis brand Dixie Elixirs & Edibles(Dixie), Colorado`s premier Medical Marijuana infused products company. Dixie Elixirs & Edibles manufactures and distributes six carefully formulated product lines consisting of well over 40 medical marijuana infused products including medicated beverages and tonics, cannabis capsules, medicated lozenges and edibles as well as a full line of topicals and salves as part of the Dixie Botanticals line of products (which were recently featured on National Geographic=E2s series =E2American Weed=E2).

*One of Colorado=E2s most recognized medical marijuana brands, Dixie Elixirs & Edibles serves over 400 of the state=E2s Medical Marijuana Centers (MMC=E2s) with new distribution points added daily.

*Medical Marijuana Inc. recently announced its wholly owned subsidiary Wellness Managed Services has signed an additional management contract which is expected to increase annual revenue by $1,700,000. The company`s 4th quarter revenue increased in excess of 100% over the prior quarter from $198,812.60 to $430,139.36. Since new management has been in place at the close of the first quarter 2011, to the close of the fourth quarter 2011, company revenue had increased an accumulative 3941%, and quarter over quarter since the first quarter 2011 have had a compounded quarterly increase of 101%.

——- PROFILE ——- Medical Marijuana Inc. (=E2MJNA=E2) is the first publicly held company vested in the medical marijuana and industrial hemp markets. The company is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.

These products range from patented and proprietary based cannabinoid products, to whole plant or isolated high value extracts for the pharmaceutical, nutraceutical and cosmiceutical industries.

The company=E2s services range from medical clinic management to the capitalization and development of existing industry leaders. These services include development of cannabinoid based health and wellness products, licensing of its proprietary testing, labeling, packaging and standardization methods for the medicinal herb industry.

Medical Marijuana Inc.=E2s patented and proprietary technologies include the only pharmaceutical grade vertical Biotechnology Company specializing in the standardization, production and extraction of medicinal cannabinoids.

Technologies also include pre and post production tracking, germplasm references, packaging and processing to ensure consistency and genetic purity.

—————– Industry Overview —————– Medical Marijuana and Industrial Hemp have over 55,000 known uses, all of which are under developed, undercapitalized and underutilized. The history of hemp as an industrial and medicinal product dates to the beginning of recorded history. It has been used as a food, medicine, building materials and fuel. It has been estimated that marijuana in the United States alone is a $110 billion market and the medical market makes up nearly $17 billion. Industrial hemp with its many uses such as fuel, food, textiles, building materials, and bioremediation is nearly impossible to quantify. Today the market is fractured in terms of international, state and local laws as well as with the business and people who participate in the industry. This is where Medical Marijuana Inc. sees much opportunity.

—————– Value Proposition —————– MJNA has a strategic unparalleled advantage to capitalize on this market in the form of its partnership with CannaBANK (“CB”), a global hemp investment firm specializing in the capitalization, development and acquisition of hemp based businesses. These companies have a broad, diverse and significant shareholder base. CB`s parent company is Hemp Deposit and Distribution Corporation which is a major shareholder of MJNA. Strategically this is advantageous to the company because CB locates, capitalizes and covers the majority of the expense in sourcing and developing these companies from due diligence through acquisition. Once developed, the asset is then transferred to the MJNA portfolio. To date CB has one of the most extensive databases of national and international marijuana and hemp laws, bands, moratoriums, approval processes, licensing requirements and the history within each country, state, county and city. The company actively tracks more than one hundred and fifty public and private companies who have expressed interest in, have invested in or are developing hemp based products. Its database also includes over five thousand hydroponic stores, three thousand dispensaries, collectives and delivery services as well as other supporting businesses such as online sales sites.

————————————————————————— List of hundreds of studies on cannabis and its AMAZING healing properties.

http://0webinfo.com/ss/link.phpM15558&N1046&C8e970abf490d59bca7e65165b8238f56&L2963 ————————————————————————— Medical Marijuana Inc., does not grow, sell or distribute marijuana. The Company operates well within all Federal guidelines in regard to Company operations and investments.

MJNA sees a myriad of opportunities to provide services, health and wellness products within this Industry =E2 thus the Company has focuses its business interests around these peripheral trades.

Recent Company acquisitions have solidified the Company=E2s place within the industry as a leader and innovator. These acquisitions of profitable, ongoing businesses are expected to add to revenues in the second half of 2012.

More exciting for investors, health care providers and patients alike, is the Company=E2s recent acquisition with an overseas developer of Cannabis extracts and compounds that contain high value CBD (Cannabidiol). MJNA will now have a pharmaceutical grade CBD line of health and wellness products that will be made from these extracts. There are four worldwide pharmaceutical companies that have synthetic CBD extracts and they do a business in excess of $1 billion annually. MJNA=E2s products are organically grown not synthetic.

The company=E2s products and intellectual property being in a socially acceptable form (non-smoked), these health and wellness products will come in the form of lozenges, gum, elixirs and other =E2delivery methods=E2. For medical professionals there will be an infusible form of the high value extract and CBD end products. CBD has been more widely researched over the past 10 years because of findings showing significant health benefits. CBD has been shown to have neuro-protective benefits for neuro-degenerative patients (MS, ALS, Parkinson=E2s, Alzheimer=E2s), have shown to carry significant anti-oxidative properties and even have been shown to fight certain forms of cancer.

MJNA feels it will have about a five year window to market these exclusive CBD-containing products that are all-natural, non-synthetic. Many established pharmaceutical companies are researching CBD because of the potential to establish a =E2blockbuster=E2 drug or drugs from the compound.

For the emerging MJNA Company, their competitive advantage, secured by international patents and IP rights, has an amazing opportunity to expand sales and distribution of these new products. Products are expected to be in the US and available for sale as soon as May 2012.

Given the proprietary technology the Company holds, MJNA may potentially come up with its own =E2blockbuster=E2 supplement =E2 perhaps a new anti-obesity formula for instance. Over time, as products emerge, the Company plans to contract and partner with other pharmaceutical companies on Clinical trials for efficacy of their formulations.

Investors will now be regularly updated each quarter with both financial reports as well as with Investor Conference calls. Our first Company call is but weeks away =E2 details to follow. Here we will discuss the myriad of opportunities and the revenue potential of the new high value extracts and products.

————————– Forward Looking Disclaimer ————————– This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana Inc to be materially different from the statements made herein.

——————————————– Food and Drug Administration(FDA) Disclosure ——————————————– Information found on this site is not intended to diagnose, cure, treat, or prevent any disease. These statements and subsequent links found within this site have not been evaluated by the Food and Drug Administration (FDA).

—————— Medical Disclaimer —————— Please read this agreement entirely and carefully before using this area of the Medical Marijuana Inc website (medicalmarijuanainc.com). By using the medicalmarijuanainc.com site, you agree to be bound by the terms and conditions below and in the medicalmarijuanainc.com Privacy Policy.

————————————- Disclaimer About Medical Information:

————————————- The information and reference materials contained here are intended solely for the general information of the reader.

It is not to be used for treatment purposes, but rather for discussion with the patient`s own physician. The information presented here is not intended to diagnose health problems or to take the place of professional medical care. The information contained herein is neither intended to dictate what constitutes reasonable, appropriate or best care for any given health issue, nor is it intended to be used as a substitute for the independent judgment of a physician for any given health issue. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. The major limitation of informational resources like medicalmarijuanainc.com is the inability to take into account the unique circumstances that define the health issues of the patient. If you have persistent health problems or if you have further questions, please consult your health care provider. All visitors to this and other medicalmarijuanainc.com associated web sites agree to read and abide by the complete terms of this agreement.

——————————————— IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY ——————————————— SmallCapVoice (SCV) is an electronic publication.

Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice.

We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. opt out of our distribution list at any time by clicking on the =E2

MJNA

5-11-12 Small Cap Daily by SmallCapVoice.com ————————– Yesterday`s Top Performers ————————– Company: Planda=C3=AD Biotechnology Inc. (OTCBB: PLPL) End of Day:

Price: 0.31 Change (%): + 0.049 (18.77) Volume: 96,208 http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L2709 Planda=C3=AD Biotechnology, Inc., through its recent acquisition of Global Energy Solutions, Ltd. and its subsidiaries, focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. Its principle holdings consist of land, farms and infrastructure in South Africa.

Since 2002, GES successfully conducted documented research producing extracts from a variety of live plant materials.

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L2709 ——————- Hot Stocks To Watch ——————- Company: Medical Marijuana Inc. (Pink Sheets: MJNA) End of Day:

Price: 0.038 Change (%): – 0.0019 (4.76) Volume: 747,219 http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L2977 Medical Marijuana Inc. (MJNA ) is the first publicly held company vested in the medical marijuana and industrial hemp industries. The company is comprised of a diversified portfolio of hemp and cannabis based businesses. These businesses range from hydroponic stores, to pharmaceutical compounds derived legally from the hemp plant. The company has gone through many changes over the course of the past few years, some expected and some unexpected due to the nature of rapidly changing legal and political environments that surround marijuana and hemp in the United States. This ability to change has been one of the corner stones of MJNA`s success in laying a much stronger foundation from which the industry can prosper.

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L2977 ——————– Other Small Cap News ——————– Company: The Graystone Company (OTCQB: GYST) http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3208 The Graystone Company Announces Effective Date of Reverse Split LIMA, Peru, May 10, 2012 (GLOBE NEWSWIRE) — The Graystone Company (OTCQB:GYST), announced today that its 1:400 reverse stock split of the Company`s Class A Common Stock will be effective May 14, 2012. All Class A common shares issued and outstanding as of March 27, 2012 will be subjected to the reverse. The Company`s shares will trade under the symbol “GYSTD” with a “D” added for 20 trading days to signify that the reverse stock split has occurred. A new CUSIP number has been assigned to the Company`s common stock as a result of the reverse split.

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3209 ————————————————– Company: CytoSorbents Corporation (OTCBB: CTSO) http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L2295 Dr. Phillip Chan Named Finalist for Ernst & Young Entrepreneur of the Year=C2=AE 2012 Award in New Jersey MONMOUTH JUNCTION, N.J., May 11, 2012 /PRNewswire/ — CytoSorbents Corporation (OTCBB: CTSO), a critical care-focused company using blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses, today announced that Dr. Phillip Chan, CEO, was named a finalist in the Ernst & Young Entrepreneur Of The Year=C2=AE 2012 program in the New Jersey region. The award recognizes outstanding entrepreneurs who have demonstrated excellence and extraordinary success in areas such as innovation, financial performance and personal commitment to their businesses and communities. Dr. Chan was selected by an independent judging panel made up of previous winners, leading CEOs, private capital investors and other regional business leaders.

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3210 ——————————————————– Company: American Energy Development Corp. (OTCBB: AEDC) http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L2275 American Energy Development Provides Drilling Update 4 on Cremer 1-1 Well NEW YORK, May 11, 2012 (GLOBE NEWSWIRE) — American Energy Development Corp. (AED) (OTCBB:AEDC), an emerging energy company involved in the acquisition, exploration, development and production of established oil and gas basins, has reported the progress of drilling the Cremer 1-1 well.

Located on the company`s Dansville Prospect, the Cremer 1-1 well was spudded on April 24, targeting a Niagaran reef structure and reached total depth of approximately 4,500 feet on May 8. The geophysical logging data was carefully examined for density, porosity and water saturation in order to determine reservoir size, quality and deliverability.

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3211 ——————————————————————————– Company: Energy Edge (Pink Sheets: EEDG) http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3212 Follow Up To Press Release Retraction: A Letter From The President of Energy Edge Dear Shareholders, In a short span of time I`ve had multiple interactions with EEDG shareholders regarding the press release retraction we posted yesterday evening. Accordingly, I feel it`s incumbent upon me to clarify and explain to everyone the events that transpired.

First and foremost, Energy Edge (OTC: EEDG) is 100% committed to moving into the residential energy market and to employing as many Veterans as possible through VetPower.org while doing so. Our concern with the press release, and the quotes and terms stated therein, was that it was approved by people within the 5 LINX organization who lacked the authority to do so.

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3213 ———– Market=C2News ———– By Christopher Johnson: Reuters Oil likely to stay high despite good supply: IEA Tension between Iran and the West is likely to keep oil prices high despite a dramatic improvement in world supply and a big build in stocks, the International Energy Agency (IEA) said on Friday.

The agency, which advises 28 industrialized nations on energy policy, said soaring global oil supply from OPEC countries and the United States far outpaced global demand, curbed by poor economic activity in developed nations.

The agency said global oil supply rose 600,000 barrels per day (bpd) to 91 million bpd in April and was now 3.9 million bpd over year ago levels, with 90 percent of the increase coming from OPEC.

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3214 ——————————————————– By Clare Kane: Reuters Global shares, commodities slide on Greek impasse, growth worries European shares and commodities fell on Friday as Greece appeared unable to form a government and Chinese data came in unexpectedly weak, fuelling fears of a global economic slowdown and keeping safe-haven German bond yields close to record lows.

The FTSEurofirst index of top European stocks dipped 0.7 percent to 1011.82 points, led by banking shares, which were hit by a shock $2 billion trading loss at top U.S. bank JPMorgan (JPM).

Read More >> http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3215 ———————– Research and Commentary ———————– Washington Extra – Surplus shocker! http://0webinfo.com/ss/link.phpM15558&N1044&C8e970abf490d59bca7e65165b8238f56&L3217 ——————————————— IMPORTANT DISCLAIMER – PLEASE READ THOROUGHLY ——————————————— SmallCapVoice (SCV) is an electronic publication.

Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice.

We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. opt out of our distribution list at any time by clicking on the =E2

AEDC · CTSO · EEDG · GYST · GYSTD · LIMA · LINX · MJNA · PLPL